Seres Therapeutics

MCRBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$48.414 M

$4.87 +1.04%

Close of 7 Aug 2026

Revenue

$789.0K

#3521 by revenue

Earnings

$5.70M

#2176 by earnings

Shares outstanding

9,941,261

Latest filing cover page

P/E ratio

8.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#350China PharmaCPHI$48.6M
#351Alaunos TherapeuticsTCRT$48.6M
#352Seres TherapeuticsMCRB$48.4M
#353Filana TherapeuticsFLNA$48.1M
#354Karyopharm TherapeuticsKPTI$48.0M

Where these numbers come from

Share counts and financials for Seres Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.